BUDECORT INHALER is indicated for the maintenance treatment of asthma as prophylactic therapy in adult and pediatric patients. It is also indicated for patients requiring oral corticosteroid therapy for asthma. Many of those patients may be able to reduce or eliminate their requirement for oral corticosteroids over time.
BUDECORT INHALER is not indicated for the relief of acute bronchospasm.
200-1,600 mcg daily, in divided doses.
200 micrograms twice daily, in the morning and in the evening. During periods of severe asthma the daily dosage can be increased up to 1600 micrograms.
In patients whose asthma is well controlled, the daily dose may be reduced below 400 micrograms but should not go below 200 micrograms.
Patients should be maintained on the lowest dose that will effectively control symptoms.
200–800 mcg daily, in divided doses.
The dose should be reduced to the minimum needed to maintain good asthma control.
History of hypersensitivity to budesonide or any of the excipients.
BUDECORT INHALER is contraindicated in the primary treatment of status asthmaticus or other acute episodes of asthma where intensive measures are required.
There are no reviews yet.